Prism Medico

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE730E01016
  • NSEID:
  • BSEID: 512217
INR
18.09
0.1 (0.56%)
BSENSE

Feb 03

BSE+NSE Vol: 3.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 701766,
    "name": "Prism Medico",
    "stock_name": "Prism Medico",
    "full_name": "Prism Medico & Pharmacy Ltd",
    "name_url": "stocks-analysis/prism-medico",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.09",
    "chg": 0.1,
    "chgp": "0.56%",
    "dir": 1,
    "prev_price": "17.99",
    "mcapval": "11.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512217,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE730E01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.98 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prism-medico-701766-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Prism Medico & Pharmacy Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prism-medico-pharmacy-ltd-fallingrising-3779289",
        "imagepath": "",
        "date": "2026-01-03 01:45:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>On 02-Jan, Prism Medico &amp; Pharmacy Ltd’s shares declined by nearly 5%, underperforming its sector by 5.32%. This drop is consistent with the stock’s broader trend of lagging behind the benchmark indices. Over the past week, the stock has fallen by 7.87%, while the Sensex gained 0.85%. Year-to-date, the stock is down 4.47%, contrasting with the Sensex’s modest 0.64% rise. The disparity is even more pronounced over longer periods, with the stock delivering a negative 22.57% return over the last year, compared to the Sensex’s positive 7.28%. Over three and five years, the stock has declined by 45.08% and 28.96% respectively, while the Sensex has surged by 40.21% and 79.16% in the same periods.</p>\n<p><strong>Technical Indicators an..."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-3771502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_mojoScore_3771502.png",
        "date": "2025-12-26 21:51:26",
        "description": "Prism Medico &amp; Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Prism Medico’s Evaluation Revised Amidst Weak Fundamentals and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3755251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedico_mojoScore_3755251.png",
        "date": "2025-12-10 10:10:07",
        "description": "Prism Medico, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market assessment reflecting challenges in its financial health and stock performance. Recent analytical changes highlight concerns over the company’s operational results and market returns, signalling a cautious outlook for investors."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3746826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3746826.png",
        "date": "2025-12-04 13:25:40",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum amid a series of consecutive losses."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3744351.png",
        "date": "2025-12-03 13:45:24",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals heightened market caution surrounding the company’s near-term prospects."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3737823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3737823.png",
        "date": "2025-12-01 09:50:25",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.96% today and exhibiting no buying interest. This distress selling comes amid a series of consecutive losses, signalling heightened investor caution in the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728113",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3728113.png",
        "date": "2025-11-25 09:40:58",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has resulted in a continuation of losses, reflecting a challenging phase for the company within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3725370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3725370.png",
        "date": "2025-11-24 11:30:41",
        "description": "Prism Medico & Pharmacy Ltd is experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment for this Non Banking Financial Company (NBFC)."
      },
      {
        "title": "Is Prism Medico overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prism-medico-overvalued-or-undervalued-3713567",
        "imagepath": "",
        "date": "2025-11-19 08:08:21",
        "description": "As of 18 November 2025, the valuation grade for Prism Medico has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. The key ratios include a PE ratio of 19.52, an EV to EBITDA of 11.84, and a Price to Book Value of 0.79. \n\nIn comparison to its peers, Prism Medico's valuation is significantly lower than that of Max Healthcare, which has a PE ratio of 77.03, and Apollo Hospitals, with a PE ratio of 63.51. Despite the fair valuation, Prism Medico has underperformed the Sensex over the past year, with a stock return of -24.32% compared to the Sensex's return of 9.48%...."
      }
    ],
    "total": 159,
    "sid": "701766",
    "stock_news_url": "https://www.marketsmojo.com/news/prism-medico-pharmacy-701766"
  },
  "announcements": [
    {
      "caption": "Undertaking Of Functional Website",
      "datetime": "30-Jan-2026",
      "details": "Please find the attached Disclosure and Kindly take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "16-Jan-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached the certificate issued by RTA. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Compliance-57 (5) : intimation after the end of quarter",
      "datetime": "02-Jan-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 57(5) of SEBI(Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached intimation for the quarter ended on 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Prism Medico & Pharmacy Ltd falling/rising?

2026-01-03 01:45:08

Recent Price Movement and Market Comparison

On 02-Jan, Prism Medico & Pharmacy Ltd’s shares declined by nearly 5%, underperforming its sector by 5.32%. This drop is consistent with the stock’s broader trend of lagging behind the benchmark indices. Over the past week, the stock has fallen by 7.87%, while the Sensex gained 0.85%. Year-to-date, the stock is down 4.47%, contrasting with the Sensex’s modest 0.64% rise. The disparity is even more pronounced over longer periods, with the stock delivering a negative 22.57% return over the last year, compared to the Sensex’s positive 7.28%. Over three and five years, the stock has declined by 45.08% and 28.96% respectively, while the Sensex has surged by 40.21% and 79.16% in the same periods.

Technical Indicators an...

Read full news article
stock-recommendationAnnouncement

Undertaking Of Functional Website

30-Jan-2026 | Source : BSE

Please find the attached Disclosure and Kindly take the same on record.

Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

16-Jan-2026 | Source : BSE

Dear Sir/Madam Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached the certificate issued by RTA. Thanking You.

Compliance-57 (5) : intimation after the end of quarter

02-Jan-2026 | Source : BSE

Dear Sir/Madam Pursuant to Regulation 57(5) of SEBI(Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached intimation for the quarter ended on 31st December 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available